| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 707982 | Null | 0.0105972823829604 | 0.17863265 |
| NSC 720447 | Null | 0.0105972823829604 | -0.27950331 |
| NSC 726267 | Null | 0.0105972823829604 | -0.10404337 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0105972823829604 | 0.24594743 |
| NSC 740 | Methotrexate | 0.0105972823829604 | 0.72723635 |
| NSC 744063 | Null | 0.0105972823829604 | 0.37028632 |
| NSC 763059 | Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride | 0.0105972823829604 | 0.40401684 |
| NSC 132279 | Null | 0.0119221520283057 | 0.5911626 |
| NSC 150289 | Null | 0.0119221520283057 | 0.34474914 |
| NSC 269719 | Estr-4-en-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (17.beta.)- | 0.0119221520283057 | 0.35474558 |